 |
|
The 100 Most Frequently Cited Articles in Ophthalmology Journals
Norio Ohba, MD;
Kumiko Nakao, MD;
Yasushi Isashiki, MD;
Ayako Ohba, MA
Arch Ophthalmol. 2007;125(7):952-960.
ABSTRACT
We screened 46 ophthalmology journals to identify the most frequently cited articles using the Science Citation Index Expanded (1975 to 2006). The 100 most-cited articles were published in 13 journals, most in the Archives of Ophthalmology (n = 30), followed by Ophthalmology (n = 27) and the American Journal of Ophthalmology (n = 11), and originated from 10 countries, led by the United States (n = 86). The topics covered by these classic articles included epidemiology of age-related macular degeneration and glaucoma, description of new diseases including cytomegalovirus retinitis, optical coherence tomography, hypotensive medications in glaucoma, laser photocoagulation to treat diabetic retinopathy and subfoveal choroidal neovascularization, photorefractive surgery, and vitrectomy to treat idiopathic macular hole. The most frequently cited articles provide a historical perspective in the scientific advancement of ophthalmology during the last 3decades.
INTRODUCTION
The number of citations an article receives after its publication reflects its effect on the scientific community.1 Publications in major journals and citations by other researchers are considered when decisions are made about grants, hiring, promotion, and tenure. Analysis of the most frequently cited articles may reveal the effect of works of colleagues and predecessors and provide a historical perspective on the scientific progress in the field of specialty. To our knowledge, this is the first study of the most frequently cited articles published in the last several decades in ophthalmology journals.
METHODS
We used the Science Citation Index Expanded provided by the ISI Web of Science (Institute for Scientific Information, Thomson Scientific, Philadelphia, Pennsylvania),2 accessed via the Internet (August 30, 2006), to determine the number of citations of articles published in 46 journals dedicated to ophthalmology and its subspecialties. Table 1 gives the 46 journals and the number of original articles and review articles examined; 15 major journals provided articles published from 1975 to the present. The 100 most frequently cited articles were selected to review publishing journal, authorship, institution, country of origin, type of article (epidemiologic study, clinical experience, randomized controlled trial, or basic science), and categories of research topics.
|
|
|
|
Table 1. Screened Journals in Ophthalmology and Its Subspecialties
|
|
|
RESULTS
References for the 100 most frequently cited articles published in the last 3 decades in ophthalmology journals are listed in Table 2 according to the number of citations they received, in descending order. These articles have been cited steadily since publication, with a half-life of more than 10 years, as illustrated by a random selection of samples (Figure). The mean number of citations per article is 318. The most-cited article received 684 citations and the least-cited article received 238 citations. These articles were published from 1975 to 2002. The oldest articles were published in 1975, and the most recent article in 2002. Approximately half of the articles were published after 1990.
|
|
|
|
Table 2. One Hundred Citation Classics in Ophthalmology and Its Subspecialties
|
|
|
|
|
|
|
Figure. Number of times cited (TC) per year after publication for articles selected from the 100 most-cited articles. The number to the left of each article indicates its rank in the citation classics list given in Table 2.
|
|
|
The 100 most frequently cited articles, or citation classics, in ophthalmology were published in 13 journals (Table 3), most in the Archives of Ophthalmology (n = 30), followed by Ophthalmology (n = 27), the American Journal of Ophthalmology (n = 11), Experimental Eye Research (n = 7), Investigative Ophthalmology and Visual Science (n = 7), and Survey of Ophthalmology (n = 7). The articles were the products of multi-institutional collaboration (n = 8), multinational collaboration (n = 6), and individual institutions (n = 86). For simplicity, in articles from multicenter study groups, the name of the coordinator was defined as the country or institution of origin. The 100 citation classics originated from 10 countries: United States (n = 86), Australia (n = 3), United Kingdom (n = 3), Germany (n = 2), and Canada, Greece,Japan, the Netherlands, Portugal, and Sweden (n = 1 each). The 100 articles were contributed by 41 institutions. Table 4 lists the leading 10 institutions, with 2 publications or more, led by The Johns Hopkins University in Baltimore, Maryland (16 publications), followed by Harvard University in Boston, Massachusetts (8 publications), and the University of Wisconsin in Madison (7 publications).
|
|
|
|
Table 3. Journals in Which the 100 Citation Classics Were Published
|
|
|
|
|
|
|
Table 4. Institutions of Origin of 2 Articles or More
|
|
|
Fourteen articles were the products of multi-institutional or multinational studies with contributions from as many as 386 participants (Table 2). The remaining 86 articles were products of individual institutions, contributed by 263 authors, ranging from 1 to 12 authors per article (mean number of authors, 4). Table 5 gives the names of 28 authors of 2 or more of the 100 most-cited articles.
|
|
|
|
Table 5. Authors With 2 Publications or More
|
|
|
Table 6 summarizes the research field and topics covered by the 100 articles. Eleven articles reported epidemiological study results, 67 dealt with clinical experience, and 22 covered basic scienceresearch. Descriptive epidemiology reported the prevalence and risk factors of age-related macular degeneration (n = 2), glaucoma and ocular hypertension (n = 2), diabetic retinopathy (n = 2), and cataract or general blinding diseases (n = 5).
|
|
|
|
Table 6. Specific Fields and Topics of the 100 Citation Classics
|
|
|
Articles in the clinical experience group were classified into 4 categories. The first category, clinical assessment, dealt with innovation of the visual acuity chart (n = 3); grading or scoring system, or electroretinography test standardization (n = 4); diagnostic imaging technologies including corneal endothelial specular microscopy and optical coherence tomography (n = 4); and retinal nerve fiber layer evaluation (n = 8). In the second category, 11 articles reported new information about clinical diseases including AIDS, idiopathic macular hole, and massive periretinal proliferation. The third category included 14 articles reporting medical therapies for glaucoma and normal-tension glaucoma (n = 8), ganciclovir treatment for cytomegalovirus retinitis (n = 2), and botulinum toxin injection for blepharospasm (n = 2). In the fourth category, 23 articles reported laser and surgical treatments including photodynamic therapy of subfoveal choroidal neovascularization (n = 4), laser correction of refractive errors (n = 6), vitrectomy for idiopathic macular hole (n = 1), trabeculectomy with adjunctive therapy (n = 5), and limbal autograft transplantation (n = 1).
Twenty-two articles were included in the category of basic science with which to achieve understanding of the pathophysiology and pathogenesis of eye disorders. This category included vascular endothelial growth factors, retinal ganglion cell apoptosis, corneal endothelial cell structure and function, and oxygen-induced retinopathy.
Of the 100 citation classics, 12 were products of randomized clinical trials (Table 2), including medications for intraocular pressure control in glaucoma, photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration, treatment of cytomegalovirus retinitis with intraocular sustained-release ganciclovir implantation, vitrectomy for the treatment of postoperative endophthalmitis, and high-dose supplementation with ascorbic acid, vitamin E, beta-carotene, and zinc for age-related macular degeneration. These were multi-institutional or multinational collaborative studies performed in the United States and Europe.
COMMENT
The number of times an article is cited in other articles is widely believed to reflect its effect and the quality of contribution by its authors. Some important articles may not be readily listed as citation classics because their substance has become such common knowledge after publication that their content is no longer cited. Other articles may be frequently cited because they have withstood the test of time. The articles published in the major journals dedicated to ophthalmology and its subspecialties were the target of this citation analysis. The pattern of citations varies among articles and, in the most-cited articles, the number of citations has remained so steady for 10 years or longer that the cumulative number of citations of a given article has increased with time after publication. The 100 citation classics are landmark articles with topics that have inspired clinical and basic research in the past 30 years. As the data show, some of the most important advances include descriptive epidemiology risk factor analysis of diabetic retinopathy, age-related macular degeneration, and glaucoma and ocular hypertension; and diagnostic imaging technologies including optic coherence tomography, laser applications for the treatment of choroidal neovascularization and correction of refractive errors, and vitreous intervention for the treatment of idiopathic macular hole and proliferative diabetic retinopathy.
Most cited classic articles originated in the United States, and only 6 articles originated in non-English-speaking countries. The findings seem consistent with the size of the US ophthalmic community and its wealth and scientific output, which dominate the international ophthalmic publications. There is, however, some evidence that US authors tend to quote articles from US journals and omit relevant references from journals published elsewhere.103 Reviewers from the United States are likely to evaluate papers submitted by US authors more favorably.104
This list of the most-cited articles in ophthalmology identifies seminal contributions and originators, indicates an increasing popularity of randomized clinical trials for acquisition of evidence-based information, and offers ophthalmology researchers hints about what makes an article a most frequently cited classic. To produce such an article, the ophthalmologist and his or her group must offer a medical or surgical innovation, worldwide influential clinical description, or discovery that has a long-lasting effect on the way we practice ophthalmology. Such a contribution should be published in the English language in a major journal.
AUTHOR INFORMATION
Correspondence: Norio Ohba, MD, Division of Orthoptics and Visual Science, Aichi Shukutoku University, Faculty of Medical Welfare, Sakuragaoka 23, Chikusa-ku, Nagoya-shi 464-8671, Japan (ohbanm{at}gctv.ne.jp).
Submitted for Publication: November 26, 2006; final revision received November 26, 2006; accepted November 28, 2006.
Financial Disclosure: None reported.
Author Affiliations: Division of Orthoptics and Visual Science, Aichi Shukutoku University, Faculty of Medical Welfare, Nagoya-shi, Japan (Dr Ohba); Department of Ophthalmology, Kagoshima University Graduate School of Medicine, Kagoshima-shi, Japan (Dr Nakao); Department of Ophthalmology, Aichi Shukutoku University Clinic (Dr Isashiki) and Department of Language Communication, Graduate School of Communication (Ms Ohba), Aichi Shukutoku University, Nagakute-cho, Japan.
REFERENCES
| |
1. Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA. 1987;257(1):52-59.
ABSTRACT
2. Thomson Scientific. ISI Web of Knowledge: the new face of research. http://scientific.thomson.com/webofknowledge. Accessed August 20, 2006.3. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91-96.
ISI
| PUBMED
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy, II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
ABSTRACT
5. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
ISI
| PUBMED
6. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual-field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100(1):135-146.
ABSTRACT
7. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
ABSTRACT
8. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report. Arch Ophthalmol. 1999;117(10):1329-1345. [published correction appears in Arch Ophthalmol. 2000;118(4):488].
FREE FULL TEXT
9. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389-393.
FREE FULL TEXT
10. Harding JJ, Dilley KJ. Structural proteins of mammalian lens: review with emphasis on changes in development, aging and cataract. Exp Eye Res. 1976;22(1):1-73.
FULL TEXT
|
ISI
| PUBMED
11. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983;96(6):710-715.
ISI
| PUBMED
12. Adamis AP, Miller JW, Bernal MT; et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118(4):445-450.
ISI
| PUBMED
13. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80(1):1-23.
ISI
| PUBMED
14. Heeger DJ. Normalization of cell responses in cat striate cortex. Vis Neurosci. 1992;9(2):181-197.
ISI
| PUBMED
15. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2:187-199.
16. Hee MR, Izatt JA, Swanson EA; et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113(3):325-332.
ABSTRACT
17. Sarks SH. Aging and degeneration in the macular region: a clinicopathological study. Br J Ophthalmol. 1976;60(5):324-341.
FREE FULL TEXT
18. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98(3):317-321.
ISI
| PUBMED
19. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53(11):740-745.
ISI
| PUBMED
20. Apple DJ, Solomon KD, Tetz MR; et al. Posterior capsule opacification. Surv Ophthalmol. 1992;37:73-116.
FULL TEXT
|
ISI
| PUBMED
21. Bird AC, Bressler NM, Bressler SB; et al, International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39(5):367-374.
ISI
| PUBMED
22. Young RW. Visual cells and concept of renewal. Invest Ophthalmol. 1976;15:700-725.
FREE FULL TEXT
23. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983;90(8):859-873.
ISI
| PUBMED
24. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32(6):375-413.
FULL TEXT
|
ISI
| PUBMED
25. Cunha-Vaz J, Faria de Abreu JR, Campos AJ. Early breakdown of blood retinal barrier in diabetes. Br J Ophthalmol. 1975;59(11):649-656.
FREE FULL TEXT
26. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109(5):654-659.
ABSTRACT
27. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92(4):472-484.
ISI
| PUBMED
28. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res. 1981;33(6):673-681.
FULL TEXT
|
ISI
| PUBMED
29. Steinberg EP, Tielsch JM, Schein OD; et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112(5):630-638.
ABSTRACT
30. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion-cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36(5):774-786.
FREE FULL TEXT
31. Bressler NM, Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP report 2. Arch Ophthalmol. 2001;119(2):198-207.
FREE FULL TEXT
32. Gospodarowicz D, Mescher AL, Birdwell CR. Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factors. Exp Eye Res. 1977;25(1):75-89.
FULL TEXT
|
ISI
| PUBMED
33. Chylack LT Jr, Wolfe JK, Singer DM; et al, Longitudinal Study of Cataract Study Group. The lens opacities classification system III. Arch Ophthalmol. 1993;111(6):831-836.
ABSTRACT
34. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Arch Ophthalmol. 1979;97(2):319-322.
ISI
| PUBMED
35. Gass JD. Idiopathic senile macular hole: its early stages and pathogenesis. Arch Ophthalmol. 1988;106(5):629-639.
ABSTRACT
36. Age-Related Eye Disease Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
FREE FULL TEXT
37. Puliafito CA, Hee MR, Lin CP; et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102(2):217-229.
ISI
| PUBMED
38. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109(12):1693-1698.
ABSTRACT
39. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion-cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107(5):453-464.
ISI
| PUBMED
40. Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? Ophthalmology. 1984;91(11):1351-1355.
ISI
| PUBMED
41. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107(1):75-80.
ABSTRACT
42. Skuta GL, Beeson CC, Higginbotham EJ; et al. Intraoperative mitomycin vs postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99(3):438-444.
ISI
| PUBMED
43. Zimmerman TJ, Kaufman HE. Beta-adrenergic blocking-agent for treatment of glaucoma. Arch Ophthalmol. 1977;95(4):601-604.
ABSTRACT
44. Wilson HR, Ferrera VP, Yo C. A psychophysically motivated model for 2-dimensional motion perception. Vis Neurosci. 1992;9(1):79-97.
ISI
| PUBMED
45. Sommer A, Katz J, Quigley HA; et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.
ABSTRACT
46. Bourne WM, Kaufman HE. Specular microscopy of human corneal endothelium in vivo. Am J Ophthalmol. 1976;81(3):319-323.
ISI
| PUBMED
47. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31(5):291-306.
FULL TEXT
|
ISI
| PUBMED
48. Smith LE, Wesolowski E, McLellan A; et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111.
FREE FULL TEXT
49. Seiler T, Wollensak J. Myopic photorefractive keratectomy with the excimer laser: one-year follow-up. Ophthalmology. 1991;98(8):1156-1163.
ISI
| PUBMED
50. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS) 7: The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-440.
FULL TEXT
|
ISI
| PUBMED
51. Leske MC, Chylack LT Jr, Wu SY. The lens opacities case-control study: risk factors for cataract. Arch Ophthalmol. 1991;109(2):244-251.
ABSTRACT
52. Alm A, Stjernschantz J, Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology. 1995;102(12):1743-1752.
ISI
| PUBMED
53. Camras CB, US Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology. 1996;103(1):138-147.
ISI
| PUBMED
54. Palestine AG, Rodrigues MM, Macher AM; et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;91(9):1092-1099.
ISI
| PUBMED
55. Sommer A, Tielsch JM, Katz J; et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090-1095.
ABSTRACT
56. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98(8):1310-1315.
ISI
| PUBMED
57. Kass MA, Heuer DK, Higginbotham EJ; et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
FREE FULL TEXT
58. Fantes FE, Hanna KD, Waring GO III, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990;108(5):665-675.
ABSTRACT
59. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: the site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99(4):635-649.
ABSTRACT
60. Rubinfeld RS, Pfister RR, Stein RM; et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99(11):1647-1654.
ISI
| PUBMED
61. International Standardization Committee. Standard for clinical electroretinography. Arch Ophthalmol. 1989;107(6):816-819.
ISI
| PUBMED
62. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114(3):299-305.
ABSTRACT
63. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96(5):709-723.
ISI
| PUBMED
64. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32(8):2201-2211.
FREE FULL TEXT
65. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch Ophthalmol. 1990;108(2):286-290.
ABSTRACT
66. Kattan HM, Flynn HW, Pflugfelder SC Jr, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology. 1991;98(2):227-238.
ISI
| |
